pain therapy market

gain in relief of pain

A woman in a lab sitting down with some test tubes

Pain therapy market » Market opportunity

Meet a huge and growing market

STUDIES IN EUROPE and the USA estimate that around 20% of the adult population suffer from moderate or severe pain persisting for more than 6 months.

The Global Pain Management Therapeutics Market (PMTM) is valued at USD 65.5 billion in 2018 and is expected to grow at 4.1% CAGR to USD 86.2 billion in 2025. US and Europe together represent 68% of the global market. A key growth driver is an aging population with increasing prevalence of chronic disorders.

The market opportunity is the lack of effective treatments for chronic pain without unwanted side-effects of existing medicines (conventional opioids, anti-depressants and gabapentinoids).


  • Treatment of chronic pain is still a clearly unmet medical need.

Latest news

View all
December 22, 2022

PharmNovo at Biostock

CEO Per von Mentzer presented PharmNovo at the BioStock - Connecting Innovation and Capital Life Science Fall Summit 2022. Watch his presentation addressing the large, unmet medical needs in the neuropathic pain market and learn more about our ongoing clinical trial and how we will achieve project milestones as PharmNovo moves forward.

Read more
December 22, 2022

Seasons Greetings 2022

The PharmNovo team would like to wish you a Merry Christmas and a Happy New Year!

Read more
October 11, 2022

Strengthening the team

PharmNovo has strengthened the team with a new experienced Project Manager and a Clinical Trial Manager

Read more
September 20, 2022

Good press in SvD

Read the story about PharmNovo and our drug candidate PN6047 for neurophatic pain and its ongoing phase I studies in Svenska Dagbladet.

Read more

By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.

Awesome 👌